Related Experiment Videos

Growth hormone release in normal children after oral clonidine 4 micrograms/kg

Insights

Oral clonidine at 4 micrograms/kg effectively stimulates growth hormone (GH) release in children. This safe and potent method provides reliable results for GH provocation testing.

Area of Science:

  • Pediatric Endocrinology
  • Pharmacology

Background:

  • Growth hormone (GH) deficiency can impact childhood development.
  • Accurate assessment of GH secretion is crucial for diagnosis and treatment.

Purpose of the Study:

  • To evaluate the efficacy and safety of oral clonidine as a GH provocative agent in healthy children.
  • To determine the optimal dosage and timing for clonidine-induced GH release.

Main Methods:

  • A cohort of 32 healthy children received an oral dose of 4 micrograms/kg of clonidine after overnight fasting.
  • Plasma GH levels were measured at baseline and at 30, 60, 90, and 120 minutes post-ingestion.
  • Adverse effects were monitored throughout the study.

Main Results:

  • Oral clonidine administration resulted in a significant increase in plasma GH levels.
  • The mean peak GH response ranged from 18.7 to 67.3 ng/ml, predominantly observed at 90 minutes.
  • No serious adverse events were reported during the study.

Conclusions:

  • Oral clonidine at a dose of 4 micrograms/kg is a safe and effective stimulant for GH release in children.
  • Clonidine provides reliable and satisfactory results for GH provocation testing.
  • This method offers a valuable tool for pediatric endocrinology assessments.

Related Concept Videos